Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
For condition-specific context, visit Type 2 Diabetes
Serve on top of 1-2 slices of whole-grain toast
Published research has reported the following reference ranges: Preclinical (rodent) models: doses in the range of 0.13 nmol/kg administered at periodic intervals to evaluate pharmacokinetics, receptor activation, and metabolic signaling responses Early-phase clinical investigations: escalating dose protocols beginning at sub-milligram weekly doses, as reported in Phase 1 and Phase 2 trial literature (Coskun et al., 2022) In vitro systems: receptor binding and activation studies conducted at nanomolar concentrations to evaluate GLP-1R, GIPR, and GCGR engagement These values are model- and protocol-specific and do not translate directly to human use
Genomics 72 , 4350 (2001)
